Blend
CJC-1295 / Ipamorelin
Custom strengths on request
Compounded medications are not FDA-approved.
What is in the vial
- CJC-12956 mg
- Ipamorelin12 mg
Blend calculator
Blend vial
Pick the blend, then the one component your dose is written for. The others follow from the vial.
mL
Dose is written for
mcg
Result
Draw to
-
- Water in the vial
- -
- Dose anchored to
- CJC-1295
What each component delivers
| Component | Delivered |
|---|---|
| CJC-12956 mg in the vial | - |
| Ipamorelin12 mg in the vial | - |
Math on the numbers above. Not medical advice; confirm concentration against the dispensed vial label.
Each component at a glance
CJC-1295
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Typical
30 or 60 microg/kg SC, single dose (best-tolerated; DAC form)
Human study
- Frequency
- Single dose; second trial: 2 or 3 weekly/biweekly doses (dose not stated)
- Route
- sc (subcutaneous)
- Course
- Trials lasted 28 and 49 d (which trial had which is not stated)
DAC form only, weight-based single doses in healthy adults; do not apply to no-DAC CJC-1295 or use as a blend vial dose.
Ipamorelin
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Start
0.03 mg/kg per dose, intravenous infusion (postoperative ileus trial)
Human study
- Frequency
- twice daily
- Route
- intravenous infusion
- Course
- postoperative day 1 to 7 or hospital discharge
Both human studies used intravenous dosing only; no subcutaneous human dosing is established, so do not extrapolate these figures to subcutaneous use.
Get a quote
Custom strengths on request. Prices are quoted per clinic.